Voxelotor

Oxbryta 500 MG Comprimidos Recubiertos con Pelicula

500 mg comprimido recubierto con películaSpainSuspendedAuthorised 5 Feb 2024

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Voxelotor

Oxbryta 500 MG Comprimidos Recubiertos con Pelicula

500 mg comprimido recubierto con películaSpainSuspendedAuthorised 5 Feb 2024

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Voxelotor
Strength: 500 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Suspended
Status in the register: Suspendido
Authorised: 5 Feb 2024
Registration: 1211622001
Marketing authorisation holder: Pfizer Europe Ma Eeig
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/21/1622